Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 18554566.
- Also identified by DOI 10.1016/j.ajog.2008.04.044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of the study was to investigate the association between maternal Rh D status, prenatal exposure to anti-D immune globulin, and the risk of autism in the offspring. Case-control study among children born from 1995 to 1999 at Kaiser Permanente Northern California hospitals. Cases (n = 400) were children with an autism diagnosis; controls (n = 410) were children without autism, randomly sampled and frequency matched to cases on sex, birth year, and birth hospital. Maternal Rh D status and anti-D immune globulin exposure were ascertained from prenatal medical records. No case-control differences were observed for maternal Rh negative status (11.5% vs 10.0%, P = .5) or prenatal anti-D immune globulin exposure (10.0% vs. 9.3%, P = .7). Risk of autism remained unassociated with maternal Rh status or prenatal exposure to anti-D immune globulins after adjustment for covariates. These data support previous findings that prenatal exposure to thimerosal-containing anti-D immune globulins does not increase the risk of autism.
Medical subject headings
- Autistic Disorder
- Prenatal Exposure Delayed Effects
- Preservatives, Pharmaceutical
- Rh-Hr Blood-Group System
- Thimerosal